期刊文献+

中医辨证治疗脂肪肝的临床研究 被引量:1

Clinical Research on Treating Fatty Liver With TCM Syndrome Differentiation
下载PDF
导出
摘要 目的:探讨分析脂肪肝临床使用中医治疗的效果。方法根据2008年6月~2012年6月我院的40例脂肪肝患者来进行研究分析。将这些患者分成治疗组和对照组,对照组患者在治疗过程接受饮食、心理和运动指导,治疗组患者除了采取对照组的治疗措施之外,增加中医辨证治疗,对两组患者的临床治疗效果进行对比分析。结果治疗组使用了中医辩证治疗之后,患者的治愈率是90%,对照组治愈率是75%,两组结果存在统计学差异性。结论使用中医辨证治疗来治疗脂肪肝能够为脂肪肝的各类型转化提供诊断参考依据,而且这也是中医治疗的特色,对治疗过程的药物选择可以提供可靠的依据,让中医治疗该疾病的效果得到提升。 Objective To investigate the clinical effect of the treatment of fatty liver in clinical use.Methods From June 2008 to June 2012 in our hospital, 40 cases of fatty liver patients were to carry out research and analysis. The patients were divided into treatment group and control group. The patients in control group were treated with diet, psychology and exercise guidance. The treatment group were treated with traditional Chinese medicine treatment. The clinical effect of two groups were compared.ResultsAfter treatment, the cure rate was 90% in the treatment group and the cure rate of the control group was 75%, and there were significant differences between the two groups. ConclusionThe use of traditional Chinese medicine treatment to treat fatty liver can provide diagnostic reference for each type of fatty liver, and this is also the characteristics of Chinese medicine treatment, the treatment process of drug selection can provide reliable basis, so that the effect of Chinese medicine treatment of the disease is raised.
作者 吕光
出处 《中国继续医学教育》 2015年第30期174-175,共2页 China Continuing Medical Education
关键词 中医辨证治疗 脂肪肝 临床疗效 Traditional Chinese medicine treatment Fatty liver Clinical effect
  • 相关文献

参考文献3

二级参考文献27

  • 1陈青莲,郑祥银,黄新平.柴胡炮制品对小白鼠实验性肝损伤的影响[J].中成药,1994,16(3):22-23. 被引量:38
  • 2王嘉会 左建华 等.二陈汤加味治疗慢性肝炎转氨酶长期升高30例[J].中西医结合肝病杂志,1995,5(2):40-40.
  • 3李向中.关于柴胡药理研究的探讨[J].中药通报,1983,8(2):39-39.
  • 4于英奇.高脂质血症与汉方[J].国外医学:中医中药分册,1986,8(2):19-21.
  • 5Hezode C, Roudot- Thoraval F, Bralet MP, et al. Factors associated with steatosis and the severety of the disease in patients with chronic hepatitis C[J].J Hepatol, 2002, 36(Suppll) :111.
  • 6Thomssen R, Bonk S, Propfe C. Association of hepatitis C virus in human sera with beta- lipoprotein[J]. Med Microbiol Immunol. (Berl),1992,181:293-300.
  • 7Monazahian M, Kippenberger S, Muller A, et al. Binding of human lipoproteins (low , very low, high density lipoprotein ) to recombinant envelope proteins of hepatitis C virus [ J ]. Med Microbiol lmmnol (berl),2000,188:177- 184.
  • 8Thorssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta - lipoproteins and immunogobulins [J].Med Microbiol Immunol (Berl), 1993,182:329- 334.
  • 9Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection [J].Semin Liver Dis, 1995,15:70-81.
  • 10Lerat H, Honda M, Tseng CTK, et al. Hepatitis C virus trancc mice as model for HCV associated liver disease (Abstract)[J]. Hepatology, 1998, (Suppl)28:498A.

共引文献28

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部